| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 285.02B | 266.44B | 257.06B | 225.18B | 216.82B |
| Gross Profit | 49.38B | 44.75B | 40.83B | 35.93B | 35.11B |
| EBITDA | 22.50B | 19.68B | 16.99B | 14.62B | 16.20B |
| Net Income | 11.51B | 8.96B | 7.28B | 7.31B | 6.91B |
Balance Sheet | |||||
| Total Assets | 296.06B | 266.44B | 260.10B | 226.91B | 221.21B |
| Cash, Cash Equivalents and Short-Term Investments | 36.06B | 28.47B | 23.38B | 22.75B | 26.60B |
| Total Debt | 48.96B | 51.81B | 51.21B | 53.09B | 53.00B |
| Total Liabilities | 170.37B | 153.37B | 151.37B | 126.47B | 126.94B |
| Stockholders Equity | 124.88B | 112.03B | 107.01B | 98.75B | 92.47B |
Cash Flow | |||||
| Free Cash Flow | 15.01B | 10.25B | 8.49B | 2.15B | 11.51B |
| Operating Cash Flow | 24.36B | 20.50B | 14.06B | 6.40B | 16.00B |
| Investing Cash Flow | -10.57B | -12.54B | -8.22B | -7.93B | -7.22B |
| Financing Cash Flow | -6.26B | -3.38B | -5.88B | -3.34B | -5.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥58.05B | 5.85 | 16.91% | 2.28% | 8.57% | 43.80% | |
71 Outperform | ¥139.04B | 13.21 | 9.14% | 2.84% | 6.97% | 28.34% | |
71 Outperform | ¥224.56B | 18.16 | ― | 3.90% | 1.23% | 11.14% | |
69 Neutral | ¥189.71B | 12.23 | 8.27% | 2.68% | 3.42% | 13.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥367.49B | 4.33 | 8.35% | 2.73% | -3.16% | -32.06% | |
46 Neutral | ¥308.50B | -2.71 | -20.43% | 3.72% | -13.16% | -410.43% |